DEPARTMENT OF OBSTETRICS & GYNECOLOGY
Research Projects
UPCOMING PROJECTS
Sl No. | Name of the Project | Sponsored by | International Collaborating Institutes | Collaboration Centre | Study Duration | Sample Size |
1 | Performance, Safety and Efficacy of a New Cryotherapy Device for Cervical Dysplasia in Low and Middle Income Countries | National Institute of Health/National Cancer Institute, (NIH/NCI), USA | Johns Hopkins Medical Institutions, Baltimore, USA, Thomas Jefferson University, Philadelphia, USA |
Karnataka Institute of Medical Sciences (KIMS), Hubballi, Karnataka The Karnatak Cancer Therapy And Research Institute (KCTRI), Hubballi, Karnataka |
May 2019 to April 2021 | 90 |
2. | Limiting Adverse Birth Outcomes in Resource -Limited Settings – The LABOR Study | Bill & Melinda Gates Foundation, USA | University of North Carolina at Chapel Hill, USA |
Fakir Mohan Medical College & Hospital, Balasore, Odisha
|
5000
|
|
3. | Effectiveness of a Postpartum Hemorrhage Initial Response Bundle (E-MOTIVE) | Bill & Melinda Gates Foundation, USA | University of Birmingham, UK | BLDE Deemed University’s Shri B. M. Patil Medical College, Vijayapura, Karnataka B.V.V.S.’s S. N. Medical College, Bagalkot, Karnataka |
4800 deliveries
|
|
4. | IV Iron for the treatment of Anemia in Pregnancy | Children’s Investment Fund Foundation (CIFF), UK | Thomas Jefferson University, Philadelphia, USA | Sawai Man Singh Medical College, Jaipur, Rajasthan | 4350 |
Ongoing Research Projects
Sl No | Principal Investigator | Co-Principal Investigator | Title of the Project | Funding Agency | Duration (From – To) | Clinical Trial Registration Details if any | Status |
1 | Dr. M. K. Swamy 2015 to 2017 Dr. Kamal Patil 2017 onwards |
Maternal DHA Supplementation and offspring neurodevelopment in India (DHANI) | Public Health Foundation of India. (PHFI) DBT (Welcome Group) Government | 2015 till date | 2015 | Ongoing | |
2 | Dr Shivaprasad S Goudar | Dr. Yeshita Pujar Dr. Shruti Andola |
The WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in preterm Newborns) Trials:” a.WHO ACTION-I TRIAL – A65913: A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries to improve newborn outcomes. b.WHO ACTION-II TRIAL – A65916: A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes. |
World Health Organization, Geneva | June 2017 to May 2019 | June 2017 | Ongoing |
3. | Dr. Shivaprasad goudar | Dr. M. B. Bellad | “Evaluating the WHO Labour Care Guide in clinical settings” | Sponsored by World Health Organization, Geneva, Switzerland | September 2019 to December 2019 | September 2019 | Ongoing |
4. | Dr. Shivaprasad Goudar | Dr. M. C. Metgud | “Prevention of Maternal and Neonatal Death/Infections With a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-income Countries): a Randomized Controlled Trial | The Global Network for Women’s and Children’s Health Research of the Eunice Kennedy Shriver | May 2019 to April 2022 | May 2019 | Ongoing |
5 | Dr. Shivaprasad Goudar | Dr. R. M. Bellad, Dr. M. B. Bellad | Low-birthweight Infant Feeding Exploration (LIFE) | Bill & Melinda Gates Foundation | November 2018 to October 2020 | November 2018 | Ongoing |
6. | Dr. Shivaprasad Goudar | Dr. M. B. Bellad, | CRADLE-4: Can Reduction of Adverse pregnancy outcomes occur with planned DeLivery vs. Expectant management in pre-eclampsia? | King’s College, London co-funded by UK Medical Research Council and Department of Biotechnology, Govt. of India | October 2018 to September 2021 | October 2018 | Ongoing |
7. | Dr. B S Kodkany | Dr. S S Goudar, Dr. S. M. Dhraded, Dr. M. C. Metgud | Maternal and Newborn Health Registry (MNH Registry) | Global Network for Women’s and Children’s Health Research of the National Institute of Child Health and Human Development, USA | January 2008 – April 2023 | January 2008 | Ongoing |
8. | Dr. Shivaprasad Goudar | Dr. Yeshita Pujar | Prevalence and outcomes of abnormal continuous wave Doppler flow indices in unselected obstetric populations in low- and middle income countries: The Umbiflow™ International Study (A65924) | World Health Organization, Geneva | August 2018 to July 2019 | August 2018 | Ongoing |
Completed Research Projects
7Dr. M. K. Swamy 2015 to 2017 Dr. Kamal Patil 2017 onwards
Maternal DHA Supplementation and offspring neurodevelopment in India (DHANI)Public Health Foundation of India. (PHFI) DBT (Welcome Group) Government2015 till date2015Completed
Sl No | Principal Investigator | Co-Principal Investigator | Title of the Project | Funding Agency | Duration (From – To) | Clinical Trial Registration Details if any | Status |
1 | Dr. B. S. Kodkany | Evaluation of an Emergency Obstetrics and New born Care Intervention Package to Reduce Adverse pregnancy Outcomes in Low Resource setting (The EmONC Trial) at 20 Primary Health Centre Areas of Belgaum District | National Institute of Child Health and Human Development, National Institutes of Health, USA | February 2009 to September 2011 | February 2009 | Completed | |
2 | Dr M B Bellad | Dr. S. S. Goudar Dr. Umesh Charantimath | Clindamycin to reduce preterm birth in low resource setting: A randomized placebo controlled trial | Thrasher Research Fund, USA | March 2012 – March 2016 | March 2012 | Completed |
3 | Dr Shivaprasad S Goudar | A phase III, randomized, double- blind, active, controlled, multinational, multicenter, non-inferiority trial using carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrhage during the third stage of labour in women delivering vaginally | Department of Reproductive Health & Research, World Health Organization, Geneva | July 2014 – June 2017 | July 2014 | Completed | |
4 | Dr Shivaprasad S Goudar (PI) | Dr M B Bellad (Co-PI) | Evaluation of the introduction of a novel device in the management of hypertension and shock in pregnancy in low-resource settings | UK Medical Research Council and Department of Biotechnology, Govt. of India | July 2015 to March 2018 | July 2015 | Completed |
5 |
Dr M B Bellad (PI)
|
Dr Shivaprasad S Goudar (Co-PI)
|
The CLIP (Community Level Interventions for Pre- Eclampsia) Cluster Randomized Controlled Trial | Bill and Melinda Gates Foundation, USA | September 2012 to June 2018 | September 2012 | Completed |
6 | Dr B S Kodkany (PI) | Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN) | The Global Network for Women’s and Children’s Health Research of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA | May 2015 to April 2019 | May 2015 | Completed | |
7 |
Dr. M. K. Swamy 2015 to 2017 Dr. Kamal Patil 2017 onwards |
Maternal DHA Supplementation and offspring neurodevelopment in India (DHANI) | Public Health Foundation of India. (PHFI) DBT (Welcome Group) Government | 2015 till date | 2015 | Completed | |
8 |
DrShivaprasad S Goudar |
Dr. YeshitaPujar Dr. Shruti Andola | The WHO ACTION (Antenatal CorticosTeroids for Improving Outcomes in preterm Newborns) Trials:” a]WHO ACTION-I TRIAL – A65913: A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries to improve newborn outcomes. b]WHO ACTION-II TRIAL – A65916: A multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, randomized trial of antenatal corticosteroids for women at risk of imminent birth in the late preterm period in hospitals in low-resource countries to improve newborn outcomes. | World Health Organization, Geneva | June 2017 to May 2019 | June 2017 | Completed |
9 |
Dr. ShivaprasadGoudar |
Dr. R. M. Bellad, Dr. M. B. Bellad | Low-birthweight Infant Feeding Exploration (LIFE) | Bill & Melinda Gates Foundation | November 2018 to October 2020 | November 2018 | Completed |